Tags

Type your tag names separated by a space and hit enter

Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
J Pharm Biomed Anal. 2014 Jan; 87:191-217.JP

Abstract

Liquid chromatography-mass spectrometry (LC-MS) is considered today as a mainstay tool for the structure characterization of minor components like impurities (IMPs) and degradation products (DPs) in drug substances and products. A multi-step systematic strategy for the purpose involves high resolution mass and multi-stage mass studies on both the drug and IMPs/DPs, followed by comparison of their fragmentation profiles. Its successful application requires consideration of many practical aspects at each step. The same are critically discussed in this review.

Authors+Show Affiliations

Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar 160062, Punjab, India.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

23706957

Citation

Narayanam, Mallikarjun, et al. "Critical Practical Aspects in the Application of Liquid Chromatography-mass Spectrometric Studies for the Characterization of Impurities and Degradation Products." Journal of Pharmaceutical and Biomedical Analysis, vol. 87, 2014, pp. 191-217.
Narayanam M, Handa T, Sharma P, et al. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products. J Pharm Biomed Anal. 2014;87:191-217.
Narayanam, M., Handa, T., Sharma, P., Jhajra, S., Muthe, P. K., Dappili, P. K., Shah, R. P., & Singh, S. (2014). Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products. Journal of Pharmaceutical and Biomedical Analysis, 87, 191-217. https://doi.org/10.1016/j.jpba.2013.04.027
Narayanam M, et al. Critical Practical Aspects in the Application of Liquid Chromatography-mass Spectrometric Studies for the Characterization of Impurities and Degradation Products. J Pharm Biomed Anal. 2014;87:191-217. PubMed PMID: 23706957.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products. AU - Narayanam,Mallikarjun, AU - Handa,Tarun, AU - Sharma,Parul, AU - Jhajra,Shalu, AU - Muthe,Praveen Kumar, AU - Dappili,Pavan Kumar, AU - Shah,Ravi P, AU - Singh,Saranjit, Y1 - 2013/04/28/ PY - 2013/04/10/received PY - 2013/04/18/accepted PY - 2013/5/28/entrez PY - 2013/5/28/pubmed PY - 2014/8/30/medline KW - (4-hydrazino-4-oxobutyl) tris(2,4,6-trimethoxyphenyl) phosphonium bromide KW - 1,2-dimethylimidazole-4-sulfonyl KW - 1-(2,4-dinitro-5-fluorophenyl)-4-methylpiperazine KW - 1-(carboxymethyl) pyridium chloride hydrazide KW - 1-(carboxymethyl) trimethylammonium chloride hydrazide KW - 2,2,2-trifluoroethanol KW - 2,2′-azobis(2-amidinopropane) dihydrochloride KW - 2,4-dinitrophenylhydrazine KW - 2-(N,N-dimethyl-amino) ethyl acrylate KW - 2-MeTHF KW - 2-acrylamino-2-methyl-propanesulfonic acid KW - 2-hydrazino-1-methyl-pyridine KW - 2-hydrazinopyridine KW - 2-methyltetrahydrofuran KW - 2-nitro-4-trifluoromethylphenylhydrazine KW - 2-nitrobenzaldehyde KW - 2NFP-APB KW - 4-(1H-pyrazol-1-yl) benzenesulfonyl KW - 4-(2-((4-bromophenethyl) dimethylammonio) ethoxy) benzenaminium dibromide KW - 4-(4-methyl-1-piperazyl)-3-nitrobenzoyl azide KW - 4-(4-nitrophenyl)-1,2,4-triazoline-3,5-dione KW - 4-(trimethylammonium) anilyl-N-hydroxysuccidimidyl carbamate iodide KW - 4-APEBA KW - 4-[2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalyl)ethyl]-1,2,4-triazoline-3,5-dione KW - 4-[2-(N,N-dimethylamino) ethylaminosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole KW - 4-[2-(N,N-dimethylamino) ethylaminosulfonyl]-7-N-methylhydrazino-2,1,3-benzoxadiazole KW - 4-[4-(6-methoxy-2-benzoxazolyl) phenyl]-1,2,4-triazoline-3,5-dione KW - 4-bromomethyl-7-methoxycoumarin KW - 4-nitro-7-piperazion-2,1,3-benzoxadiazole KW - 7-chloro-4-nitro-2,1,3-benzoxadiazole KW - 7-fluoro-4-nitro-2,1,3-benzoxadiazole KW - AAPH KW - ACN KW - AIBN KW - AMDSA KW - APCI KW - API KW - APPI KW - APZ KW - BMC KW - CHEFOG KW - CID KW - Characterization KW - DAABD-AE KW - DAABD-MHz KW - DAPB KW - DBA KW - DCU KW - DFT KW - DIPEA KW - DMAE KW - DMAP KW - DMEQTAD KW - DMF KW - DMIS KW - DMSO KW - DNPH KW - DPs KW - Da KW - Dalton KW - Degradation products KW - Dns-Cl KW - Dns-Hz KW - ESI KW - ESI-MS KW - ESI-MS/TOF KW - FT-ICR KW - GirP KW - GirT KW - H/D KW - HILIC KW - HMP KW - HP KW - HPLC KW - HRMS KW - IHD KW - IMPs KW - IR KW - IUPAC KW - Impurities KW - International Union of Pure and Applied Chemistry KW - LC KW - LC-ESI-MS KW - LC–MS KW - LOQ KW - MBOTAD KW - MDMAES KW - MNBDH KW - MS KW - MS(n) KW - MS-TOF KW - N-methyl-4-hydrazino-7-nitrobenzofurazan KW - NA KW - NBA KW - NBD-Cl KW - NBD-F KW - NBDPZ KW - NFPH KW - NH(4)OH KW - NIT KW - NMR KW - NPTAD KW - NSAIDs KW - PABA KW - PAHs KW - PBS KW - PFB-Br KW - PFPA KW - PGF2α KW - PPZ KW - PS KW - Practical aspects KW - Q-TOF KW - RDB KW - RP-HPLC KW - S-pentafluorophenyl tris(2,4,6-trimethoxyphenyl) phosphonium acetate bromide KW - SRM KW - Strategy KW - TFA KW - TFE KW - THAS KW - THF KW - TMAE KW - TMPP KW - TMPP-AcPFP KW - TMPP-PrG KW - TOF KW - TSH KW - UV KW - X-ray Diffraction KW - XRD KW - [3-(2-nitro-4-trifluoromethylphenyl) aminophenyl] dihydroxyborane KW - [M+H](+) KW - acetonitrile KW - ammonium hydroxide KW - atmospheric pressure chemical ionization KW - atmospheric pressure ionization KW - atmospheric pressure photoionization KW - azobisisobutyronitrile KW - chemical formula generator KW - collision-induced dissociation KW - dansyl chloride KW - dansyl hydrazine KW - dansyl-3-aminophenylboronic acid KW - degradation products KW - density functional theory KW - di-n-butyl amine KW - dicyclohexyl urea KW - diisopropylethylamine KW - dimethyl amino pyridine KW - dimethyl sulfoxide KW - dimethylformamide KW - electrospray ionization KW - electrospray ionization mass spectrometry/time of flight KW - electrospray ionization-mass spectrometry KW - fourier transform-ion cyclotron resonance KW - high performance liquid chromatography KW - high resolution mass spectrometry KW - hydrogen/deuterium KW - hydrophilic interaction liquid chromatography KW - impurities KW - index of hydrogen deficiency KW - infrared KW - isonicotinoyl azide KW - limit of quantification KW - liquid chromatography KW - liquid chromatography-electrospray ionization-mass spectrometry KW - liquid chromatography–mass spectrometry KW - mM KW - mass spectrometry KW - mass spectrometry-time of flight KW - milli mass unit KW - millimolar KW - mmu KW - molecular ion KW - mono(dimethylaminoethyl) succinyl imidazolide KW - multi stage mass spectrometry KW - naphthylisothiocyanate KW - non-steroidal anti-inflammatory drugs KW - nuclear magnetic resonance KW - p-toluenesulfonylhydrazide KW - para-amino benzoic acid KW - parts per million KW - pentafluorobenzyl bromide KW - pentafluoropropionic acid anhydride KW - polycyclic aromatic hydrocarbons KW - ppm KW - prostaglandin F2α KW - pyridine-3-sulfonyl KW - quadrupole-time of flight KW - reversed phase-high performance liquid chromatography KW - ring plus double bonds KW - selected reaction monitoring KW - tetrahydrofuran KW - time of flight KW - trifluoroacetic acid KW - trimethyl amino-ethylalcohol KW - tris(2,4,6-trimethoxyphenyl) phosphine KW - ultra violet SP - 191 EP - 217 JF - Journal of pharmaceutical and biomedical analysis JO - J Pharm Biomed Anal VL - 87 N2 - Liquid chromatography-mass spectrometry (LC-MS) is considered today as a mainstay tool for the structure characterization of minor components like impurities (IMPs) and degradation products (DPs) in drug substances and products. A multi-step systematic strategy for the purpose involves high resolution mass and multi-stage mass studies on both the drug and IMPs/DPs, followed by comparison of their fragmentation profiles. Its successful application requires consideration of many practical aspects at each step. The same are critically discussed in this review. SN - 1873-264X UR - https://www.unboundmedicine.com/medline/citation/23706957/Critical_practical_aspects_in_the_application_of_liquid_chromatography_mass_spectrometric_studies_for_the_characterization_of_impurities_and_degradation_products_ DB - PRIME DP - Unbound Medicine ER -